Chester County News and Community Website
WILMINGTON, DE — AstraZeneca’s experimental cancer drug sonesitatug vedotin reduced the risk of death by 53% in patients receiving third-line or later treatment for advanced gastric and related cancers, according …
AstraZeneca Drug Cuts Death Risk in Advanced Gastric Cancer Read More
PHILADELPHIA, PA — The U.S. Food and Drug Administration has granted accelerated approval to GSK’s Jemperli as a standalone treatment for certain patients with locally advanced rectal cancer, creating an …
FDA Approves GSK’s Jemperli for Certain Rectal Cancer Patients Read More
PHILADELPHIA, PA — Medicus Pharma Ltd. (NASDAQ: MDCX) is concentrating its drug-development investments on targeted cancer therapies while pursuing partnerships to limit future financing requirements, a strategic shift that follows …
Medicus Pharma Shifts Focus to Oncology Amid Stock Volatility Read More
DOYLESTOWN, PA — Aprea Therapeutics, Inc. (NASDAQ: APRE) will present updated interim results from its Phase 1 trial of WEE1 inhibitor APR-1051 in November, providing a new clinical readout from …
Aprea to Present Updated APR-1051 Cancer Trial Data Read More
PLYMOUTH MEETING, PA — Every cancer center responding to a National Comprehensive Cancer Network survey reported at least one anti-cancer drug shortage in late August, extending a supply problem that …
Cancer Drug Shortages Persist at Major U.S. Centers Read More
PHILADELPHIA, PA — Fore Biotherapeutics will continue its FORTE study of plixorafenib as planned after an independent monitoring committee cleared the first interim efficacy analysis of its BRAF fusion cohort, …
Fore Bio Clears Interim Review in BRAF Fusion Cancer Study Read More
KING OF PRUSSIA, PA — SEED Therapeutics has advanced its experimental cancer treatment into a third dosing cohort in a first-in-human clinical trial, establishing early evidence that the drug degrades …
SEED Advances Cancer Drug as Human Trial Reaches Third Cohort Read More WILMINGTON, DE — AstraZeneca’s experimental antibody-drug conjugate sonesitatug vedotin improved overall survival in a Phase III trial of previously treated CLDN18.2-positive advanced gastric and related cancers, potentially broadening targeted treatment …
AstraZeneca Drug Extends Survival in Advanced Gastric Cancer Read More
WILMINGTON, DE — Incyte Corp. (Nasdaq: INCY) will present early clinical data on two cancer treatments that have advanced into Phase 3 testing at the ESMO Congress in Madrid this …
Incyte Advances Two Cancer Drugs as ESMO Congress Nears Read More
CONSHOHOCKEN, PA — Cencora has entered an agreement with Kite, a unit of Gilead Sciences, to distribute two FDA-approved CAR T-cell cancer therapies across a growing network of treatment centers, …
Cencora, Kite Expand CAR-T Distribution Network as Access Grows Read More